Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jul;14(4):215-20.
doi: 10.1155/2003/781794.

Epidemiological and economic burden of pneumococcal diseases in Canadian children

Affiliations

Epidemiological and economic burden of pneumococcal diseases in Canadian children

Geneviève Petit et al. Can J Infect Dis. 2003 Jul.

Abstract

Background: With the arrival of a new conjugate pneumococcal vaccine, it is important to estimate the burden of pneumococcal diseases in Canadian children. The epidemiological data and the economic cost of these diseases are crucial elements in evaluating the relevance of a vaccination program.

Methods: Using provincial databases, ad hoc surveys and published data, age-specific incidence rates of pneumococcal infections were estimated in a cohort of 340,000 children between six months and nine years of age. The costs of these diseases to the health system and to families were also evaluated using data from Quebec and Manitoba.

Results: Cumulative risks were one in 5000 for pneumococcal meningitis, one in 500 for bacteremia and one in 20 for pneumonia, leading to 16 deaths in the cohort. About 262,000 otitis media episodes and 32,000 cases of myringotomy with ventilation tube insertion were attributable to Streptococcus pneumoniae. Societal costs were estimated at $125 million, of which 32% was borne by the health system and 68% was borne by families. Invasive infections represented only 2% of total costs, while 84% were generated by otitis media.

Conclusion: Pneumococcal infections represent a significant burden for Canadian children and society that could be significantly reduced through immunization.

Keywords: Canada; Economics; Epidemiology; Pneumococcal infections.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Number of cases of pneumococcal-related outcomes in a cohort of 340,000 Canadian children between six months and nine years of age. MVT* Myringotomy with ventilation tube insertion

References

    1. Peter G, Klein JO. Streptococcus pneumoniae In: Long SS, Pickerin LK, Prober CG, eds. Principles and practice of pediatric infectious diseases. New York: Churchill Livingstone, 1997:828-35.
    1. National Advisory Committee on Immunization (NACI). Statement on recommended use of pneumococcal conjugate vaccine. CCDR. <http://www.hc-sc.gc.ca/pphb-dgspsp/publicat/ccdr-rmtc/02vol28/28sup/acs... (Version current at June 30, 2003).
    1. MacDonald N, Embree J. Access to vaccines: A call to action. Can J Infect Dis 2003;14:9-13. - PMC - PubMed
    1. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000;19:187-95. - PubMed
    1. Black S, Shinefield H, Ray P, et al. Efficacy of heptavalent conjugate pneumococcal vaccine (Wyeth Lederle) in 37,000 infants and children: Impact on pneumonia, otitis media and an update on invasive disease-Results extended follow-up of the efficacy trial cohort. 2nd International Symposium on Pneumococci and Pneumococcal Diseases. Sun City, South Africa, March 19 to 23, 2000. (Abst)

LinkOut - more resources